The ground-breaking synergy of H. Pylori Fight Advanced Formula reflects the latest scientific advances in the fight against the pathogenic bacteria Helicobacter pylori (or H. pylori). This 'premium natural treatment' is part of our digestion and oro-gastrointestinal health.
The premium formulation H. Pylori Fight Advanced Formula combines the excellent postbiotic Pylopass™ with 3 carefully-selected probiotics, as well as inulin and mastic gum, for unprecedented efficacy.
A Premium, Natural Treatment with no Antibiotics, Targeted at Helicobacter pylori
An improved version of our famous the synergistic formulation H. Pylori Fight Advanced Formula combines all the most promising compounds for fighting Helicobacter pylori:
- Pylopass™ DSM17648: supported by more than 10 clinical studies, this patented postbiotic obtained from an inactivated probiotic strain of Lactobacillus reuteri, already a central component of H. Pylori Fight, is able to bind specifically to Helicobacter pylori bacteria. This co-aggregation significantly impedes its mobility and prevents it from adhering to the gastric mucosa. A study of 11 adults testing positive for H. pylori showed a reduction in bacterial load in 62.5% of participants after 28 days' supplementation (1).
- Lactobacillus acidophilus: this lactic acid bacteria present in fermented dairy products helps promote a balanced gut microbiota. Studies also show it adheres to the gastric mucosa, preventing H. pylori from doing so itself. Other studies suggest that Lactobacillus acidophilus may also modulate the immune response and produce organic acids and other compounds able to inhibit the growth of H. pylori (2-3).
- Bifidobacterium bifidum: this probiotic strain, often used for treating gastritis associated with Helicobacter pylori, acts in a similar way to Lactobacillus acidophilus. By attaching to the lining of the stomach, it competes with Helicobacter pylori, thus reducing the number of potential attachment sites for this pathogenic bacteria. Bifidobacterium bifidum may also support immunity (4-5).
- Streptococcus thermophilus: this probiotic’s exopolysaccharides have also been shown to attach to the gastric epithelium (the first layer of the gastric mucosa which comes into contact with the contents of the stomach), and so these too reduce adhesion of Helicobacter pylori (6).
- Inulin: this fiber, typically described as a natural prebiotic, is found in various vegetables (chicory, artichoke, garlic, etc.). It supports the benefits of this microbiotic combo by 'feeding' the good bacteria and promoting their growth (7).
- Mastic gum: obtained from the mastic tree, this resin may, according to the scientific literature, have a bactericidal effect beneficial in reducing colonization by Helicobacter pylori. Its effects are thought to be due to its acid fraction composed of terpene acids (8). It may also help to restore the gastric epithelium.
Reminder: What Exactly is H. pylori Bacteria?
Helicobacter pylori is a Gram-negative, spiral-shaped bacterium which colonizes the inner lining of the stomach (9). Equipped with formidable adaptive mechanisms, it is one of the few pathogens able to survive in such an acidic environment. In particular, it produces an enzyme called urease which converts urea into ammonia, thus reducing stomach acidity and helping it proliferate in mucus (10). Once established, it will not go away by itself, persisting throughout life if not properly eradicated.
H. pylori contamination is extremely common, affecting around 50% of the world’s population (11). It usually occurs in childhood, primarily through direct contact with gastric secretions (regurgitation, vomiting...), or more rarely through stools, especially in developing countries with poor hygiene conditions. It can remain symptomless for long periods, but as we will see below, it can sometimes lead to serious complications.
Helicobacter pylori: What are the Symptoms?
H. pylori causes chronic inflammation of the stomach (gastritis) which usually goes unnoticed (12). The vast majority of people infected will remain asymptomatic throughout their lives. Certain individuals, however, will suffer recurring digestive discomfort (pain and/or acid reflux, belching, nausea, vomiting, loss of appetite...) suggestive of H. pylori (13), though this not typical and is sometimes attributable to other causes.
Helicobacter pylori Infection: Is it Serious?
Helicobacter pylori is all the more insidious because it develops quietly, often over several decades. Indeed, over the long term, it is thought to cause issues affecting the stomach and/or duodenum, the first part of the small intestine in 10% of those infected (14).
Very rarely (in around 1% of cases), carriers of the bacterium will go on to develop gastric problems. Though this is extremely rare, H. pylori does appear to be responsible for almost 80% of stomach issues, hence the importance of establishing a treatment strategy as soon as possible after diagnosis to minimise this risk (15).
Helicobacter pylori: Is there a Blood Test?
In the absence of any emergency criteria, H. pylori infection can be ruled out by a blood test which detects IgG antibodies against the bacteria: a negative result automatically excludes contamination (16). There are two other lab tests that can be performed to detect the bacteria: the stool antigen test and the urea breath test (usually used at a later stage to monitor elimination of the bacteria following treatment) (17).
In the case of a positive result, a family history of stomach issues or a particular clinical context, an upper endoscopy or fibroscopy is the gold-standard diagnostic procedure (18). Taking and culturing a sample of cells from the stomach wall (biopsy) will confirm the presence of H. pylori and test its susceptibility to available antibiotics by establishing an antibiogram. Another advantage of an endoscopy is that it can reveal potential lesions caused by the bacteria.
What Antibiotics are Available for Treating H. pylori?
H. pylori is susceptible to only a handful of anti-infectious molecules. If it has been possible to test the bacteria’s susceptibility, conventional treatment is based on triple therapy consisting of a proton pump inhibitor (PPI) and two antibiotics. If a test has not been possible, 'probabilistic' quadruple therapy combining a PPI, antibacterial and/or a bismuth salt, is usually prescribed (19).
However, antibiotic treatment is far from infallible: it fails in 10% to 20% of cases. As well as poor adherence to treatment, this failure seems to be new evidence of antibiotic resistance (20). The World Health Organization (WHO) has therefore classified this bacterium as a "priority pathogen for the research and development of new antibiotics."
Supplements to Take Alongside H. Pylori Fight Advanced Formula
To help restore the gastric mucosa, we would suggest also taking a deglycyrrhizinated liquorice root supplement which supports gastrointestinal health by promoting mucus secretion, as well as as zinc helps protect cells from oxidative stress (21-22).
To relieve the gastric inflammation caused by H. pylori, you could also take turmeric (such as our product which offers unrivaled absorption). Turmeric root has anti-inflammatory and antioxidant properties and has been used for thousands of years in Ayurvedic medicine to support digestive processes (23).
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Daily dose: 2 capsules
Number of doses per pack: 30 |
Amount per dose |
Inulin |
1,000 mg |
Mastic gum |
175 mg |
Pylopass™ (Lactobacillus reuteri) DSM17648 |
100 mg (10 billion CFU) |
Lactobacillus acidophilus |
1 billion CFU |
Bifidobacterium bifidum |
1 billion CFU |
Streptococcus thermophilus |
1 billion CFU |
Other ingredients: white rice flour.
Recommended Daily Allowances not defined.
Pylopass™, Organobalance, Germany. |
Adults: Take 2 vegetarian capsules a day.
Attention: keeps best in a cool place.
Precautions: do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used as a substitute for a varied, balanced diet or a healthy lifestyle. Keep out of children’s reach. Store away from light, heat, and humidity. As with any nutritional supplement, consult a health care practitioner before use if you are pregnant, breastfeeding, or have a medical condition.
- Buckley M, Lacey S, Doolan A, Goodbody E, Seamans K. The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study. BMC Nutr. 2018 Dec 7;4:48. doi: 10.1186/s40795-018-0257-4. PMID: 32153909; PMCID: PMC7050722.
- Yang YJ, Chuang CC, Yang HB, Lu CC, Sheu BS. Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFκB pathways. BMC Microbiol. 2012 Mar 19;12:38. doi: 10.1186/1471-2180-12-38. PMID: 22429929; PMCID: PMC3340303.
- Asgari B, Kermanian F, Hedayat Yaghoobi M, Vaezi A, Soleimanifar F, Yaslianifard S. The Anti-Helicobacter pylori Effects of Lactobacillus acidophilus, L. plantarum, and L. rhamnosus in Stomach Tissue of C57BL/6 Mice. Visc Med. 2020 Apr;36(2):137-143. doi: 10.1159/000500616. Epub 2019 May 14. PMID: 32356850; PMCID: PMC7184849.
- Shirasawa Y, Shibahara-Sone H, Iino T, Ishikawa F. Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells. J Dairy Sci. 2010 Oct;93(10):4526-34. doi: 10.3168/jds.2010-3274. PMID: 20854986.
- Shibahara-Sone H, Gomi A, Iino T, Kano M, Nonaka C, Watanabe O, Miyazaki K, Ohkusa T. Living cells of probiotic Bifidobacterium bifidum YIT 10347 detected on gastric mucosa in humans. Benef Microbes. 2016 Jun;7(3):319-26. doi: 10.3920/BM2015.0138. Epub 2016 Mar 1. PMID: 26925600.
- Marcial G, Villena J, Faller G, Hensel A, de Valdéz GF. Exopolysaccharide-producing Streptococcus thermophilus CRL1190 reduces the inflammatory response caused by Helicobacter pylori. Benef Microbes. 2017 May 30;8(3):451-461. doi: 10.3920/BM2016.0186. Epub 2017 May 15. PMID: 28504579.
- Hughes RL, Alvarado DA, Swanson KS, Holscher HD. The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review. Adv Nutr. 2022 Mar;13(2):492-529. doi: 10.1093/advances/nmab119. Epub 2023 Feb 10. PMID: 34555168; PMCID: PMC8970830.
- Paraschos S, Magiatis P, Mitakou S, Petraki K, Kalliaropoulos A, Maragkoudakis P, Mentis A, Sgouras D, Skaltsounis AL. In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori. Antimicrob Agents Chemother. 2007 Feb;51(2):551-9. doi: 10.1128/AAC.00642-06. Epub 2006 Nov 20. PMID: 17116667; PMCID: PMC1797732.
- de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, Neves PHM, de Melo FF. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019 Oct 7;25(37):5578-5589. doi: 10.3748/wjg.v25.i37.5578. PMID: 31602159; PMCID: PMC6785516.
- Mobley HL, Hu LT, Foxal PA. Helicobacter pylori urease: properties and role in pathogenesis. Scand J Gastroenterol Suppl. 1991;187:39-46. PMID: 1775923.
- Parikh NS, Ahlawat R. Helicobacter Pylori. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534233/
- Azer SA, Awosika AO, Akhondi H. Gastritis. [Updated 2023 Oct 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544250/
- Öztekin M, Yılmaz B, Ağagündüz D, Capasso R. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases. 2021 Sep 23;9(4):66. doi: 10.3390/diseases9040066. PMID: 34698140; PMCID: PMC8544542.
- Narayanan M, Reddy KM, Marsicano E. Peptic Ulcer Disease and Helicobacter pylori infection. Mo Med. 2018 May-Jun;115(3):219-224. PMID: 30228726; PMCID: PMC6140150.
- Raj P, Thompson JF, Pan DH. Helicobacter pylori serology testing is a useful diagnostic screening tool for symptomatic inner city children. Acta Paediatr. 2017 Mar;106(3):470-477. doi: 10.1111/apa.13724. Epub 2017 Jan 20. PMID: 28024098; PMCID: PMC5303165.
- Sankararaman S, Moosavi L. Urea Breath Test. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542286/
- Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007 Apr;20(2):280-322. doi: 10.1128/CMR.00033-06. PMID: 17428887; PMCID: PMC1865594.
- Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018 Jan;102(1):1-7. doi: 10.1007/s00253-017-8535-7. Epub 2017 Oct 26. PMID: 29075827; PMCID: PMC5748437.
- Khien VV, Thang DM, Hai TM, Duat NQ, Khanh PH, Ha DT, Binh TT, Dung HDQ, Trang TTH, Yamaoka Y. Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam. Gut Liver. 2019 Sep 15;13(5):483-497. doi: 10.5009/gnl18137. PMID: 31009957; PMCID: PMC6743798.
- Jalilzadeh-Amin G, Najarnezhad V, Anassori E, Mostafavi M, Keshipour H. Antiulcer properties of Glycyrrhiza glabra L. extract on experimental models of gastric ulcer in mice. Iran J Pharm Res. 2015 Fall;14(4):1163-70. PMID: 26664383; PMCID: PMC4673944.
- Skrovanek S, DiGuilio K, Bailey R, Huntington W, Urbas R, Mayilvaganan B, Mercogliano G, Mullin JM. Zinc and gastrointestinal disease. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):496-513. doi: 10.4291/wjgp.v5.i4.496. PMID: 25400994; PMCID: PMC4231515.
- Kwiecien S, Magierowski M, Majka J, Ptak-Belowska A, Wojcik D, Sliwowski Z, Magierowska K, Brzozowski T. Curcumin: A Potent Protectant against Esophageal and Gastric Disorders. Int J Mol Sci. 2019 Mar 24;20(6):1477. doi: 10.3390/ijms20061477. PMID: 30909623; PMCID: PMC6471759.